Related Experiment Video
Updated: Jun 23, 2026
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
Sulfur- or selenium-substituted Nile blue-based superoxide radical generators for precise photodynamic therapy and
Guo Li1, Yingqi Gao1, Kun Qian1
1Jiangsu Key Laboratory of Advanced Medical Analysis and Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangsu, P. R. China. ylqin@ntu.edu.cn.
Abstract:
Photodynamic therapy (PDT) and immunotherapy have emerged as leading practices in the treatment of cancer in the fields of biology and medical sciences. Nevertheless, most photosensitizers exhibit off-targeting, which renders them unable to achieve precise and efficient cancer therapy. Additionally, the hypoxic tumor microenvironment restricts the generation of singlet oxygen, thereby limiting the effectiveness of type II PDT. Unlike traditional type II photosensitizers, type I photosensitizers that generate superoxide radicals have garnered significant attention for photoimmunotherapy. A few systematic elucidations have been reported thus far, focusing on sulfur- or selenium-substituted Nile blue-based type I superoxide radical generators designed to potentiate photo-immunotherapy. This feature article provides a comprehensive overview of the latest achievements in the development of sulfur- or selenium-substituted Nile blue-based superoxide radical generators, aiming to facilitate the design of precise type I photosensitizers for accurate photoimmunotherapy. The present challenges and future explorations of photoimmunotherapy are also carefully deliberated, with the hope that this work will inspire more researchers to explore innovative clinical applications using Nile blue analogue-based superoxide radical materials.
Insights
Researchers are developing novel sulfur- or selenium-substituted Nile blue-based photosensitizers for type I photodynamic therapy (PDT). These agents generate superoxide radicals, offering a promising strategy for precise cancer immunotherapy, especially in hypoxic tumors.
Area of Science:
- Biology
- Medical Sciences
- Oncology
- Photochemistry
Background:
- Photodynamic therapy (PDT) and immunotherapy are key cancer treatments.
- Current photosensitizers often lack targeting precision, limiting efficacy.
- Hypoxic tumors impede traditional type II PDT by reducing singlet oxygen generation.
Purpose of the Study:
- To provide a comprehensive overview of sulfur- or selenium-substituted Nile blue-based type I photosensitizers.
- To highlight their potential in potentiating photoimmunotherapy.
- To guide the design of precise photosensitizers for cancer treatment.
Main Methods:
- Review of recent advancements in sulfur- and selenium-substituted Nile blue derivatives.
- Analysis of type I photosensitizers generating superoxide radicals.
- Discussion of challenges and future directions in photoimmunotherapy.
Main Results:
- Sulfur- or selenium-substitution in Nile blue analogues yields effective type I photosensitizers.
- These compounds generate superoxide radicals, overcoming hypoxia limitations.
- Nile blue derivatives show promise for targeted cancer photoimmunotherapy.
Conclusions:
- Sulfur- or selenium-substituted Nile blue-based compounds are effective type I photosensitizers.
- These agents offer a viable strategy for enhancing photoimmunotherapy, particularly in hypoxic tumor environments.
- Further research into Nile blue analogues could lead to innovative clinical applications for cancer treatment.
More Related Videos
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
07:24Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal
Published on: September 12, 2025
